These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25423226)

  • 1. Genetic factors associated with severe cutaneous adverse reactions--reply.
    Chung WH; Hung SI
    JAMA; 2014 Nov; 312(20):2166. PubMed ID: 25423226
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic factors associated with severe cutaneous adverse reactions.
    Lozano R
    JAMA; 2014 Nov; 312(20):2165-6. PubMed ID: 25423224
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
    Chung WH; Chang WC; Lee YS; Wu YY; Yang CH; Ho HC; Chen MJ; Lin JY; Hui RC; Ho JC; Wu WM; Chen TJ; Wu T; Wu YR; Hsih MS; Tu PH; Chang CN; Hsu CN; Wu TL; Choon SE; Hsu CK; Chen DY; Liu CS; Lin CY; Kaniwa N; Saito Y; Takahashi Y; Nakamura R; Azukizawa H; Shi Y; Wang TH; Chuang SS; Tsai SF; Chang CJ; Chang YS; Hung SI; ;
    JAMA; 2014 Aug; 312(5):525-34. PubMed ID: 25096692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between
    Phung TH; Cong Duong KN; Junio Gloria MA; Nguyen TK
    Pharmacogenomics; 2022 Jan; 23(1):49-59. PubMed ID: 34816768
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.
    Chang CC; Ng CC; Too CL; Choon SE; Lee CK; Chung WH; Hussein SH; Lim KS; Murad S
    Pharmacogenomics J; 2017 Mar; 17(2):170-173. PubMed ID: 26927288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children.
    Manuyakorn W; Siripool K; Kamchaisatian W; Pakakasama S; Visudtibhan A; Vilaiyuk S; Rujirawat T; Benjaponpitak S
    Pediatr Allergy Immunol; 2013 May; 24(3):299-303. PubMed ID: 23551241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin-associated hypersensitivity syndrome with features of DRESS and TEN/SJS.
    Viera MH; Perez OA; Patel JK; Jones I; Berman B
    Cutis; 2010 Jun; 85(6):312-7. PubMed ID: 20666193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin.
    Aydin F; Cokluk C; Senturk N; Aydin K; Canturk MT; Turanli AY
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):588-90. PubMed ID: 16684289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis.
    Wu X; Liu W; Zhou W
    J Clin Pharm Ther; 2018 Jun; 43(3):408-413. PubMed ID: 29274302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse effects of antiepileptic drugs].
    Takahashi Y; Watanabe H; Yoshitomi S; Tsukamoto K; Yamaguchi T
    Nihon Rinsho; 2014 May; 72(5):908-19. PubMed ID: 24912294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics: reality or fiction? Or are we there yet?
    Lopes-Cendes I; Guerreiro CA
    Arq Neuropsiquiatr; 2011 Apr; 69(2A):151-2. PubMed ID: 21537550
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefepime Associated With Phenytoin Induced Stevens-Johnson Syndrome.
    Marco-Del Río J; Domingo-Chiva E; Cuesta-Montero P; Valladolid-Walsh A; García-Martínez EM
    Am J Ther; 2017; 24(4):e481-e484. PubMed ID: 28692440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe intoxication after phenytoin infusion: a preventable pharmacogenetic adverse reaction.
    Citerio G; Nobili A; Airoldi L; Pastorelli R; Patruno A
    Neurology; 2003 Apr; 60(8):1395-6. PubMed ID: 12707459
    [No Abstract]   [Full Text] [Related]  

  • 14. Stevens-Johnson syndrome in patients on phenytoin and cranial radiotherapy.
    Khafaga YM; Jamshed A; Allam AA; Mourad WA; Ezzat A; Al Eisa A; Gray AJ; Schultz H
    Acta Oncol; 1999; 38(1):111-6. PubMed ID: 10090698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B*1502 increases the risk of phenytoin or lamotrigine induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: evidence from a meta-analysis of nine case-control studies.
    Li X; Yu K; Mei S; Huo J; Wang J; Zhu Y; Zhao Z
    Drug Res (Stuttg); 2015 Feb; 65(2):107-11. PubMed ID: 24871931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic involvement in Stevens-Johnson syndrome.
    Powell N; Munro JM; Rowbotham D
    Postgrad Med J; 2006 Jun; 82(968):e10. PubMed ID: 16754699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of the HLA-A*3101 allele in a familial case of drug reaction with eosinophilia and systemic symptoms, secondary to carbamazepine.
    Anjum N; Polak ME; Ardern-Jones M; Cooper HL
    Clin Exp Dermatol; 2014 Apr; 39(3):307-9. PubMed ID: 24635066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel.
    Maggio N; Firer M; Zaid H; Bederovsky Y; Aboukaoud M; Gandelman-Marton R; Noyman I; Ekstein D; Blatt I; Marom E; Schwartzberg E; Israel S; Ingber A; Brautbar C; Eyal S
    J Clin Pharmacol; 2017 Jul; 57(7):823-829. PubMed ID: 28181259
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
    Locharernkul C; Loplumlert J; Limotai C; Korkij W; Desudchit T; Tongkobpetch S; Kangwanshiratada O; Hirankarn N; Suphapeetiporn K; Shotelersuk V
    Epilepsia; 2008 Dec; 49(12):2087-91. PubMed ID: 18637831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome following concurrent phenytoin and holocranial radiotherapy.
    Goyal S; Biswas A; Puri T; Mohanti BK
    Acta Oncol; 2010; 49(2):259-60. PubMed ID: 19888894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.